Large Clinical Trial by the Centers for Disease Control and Prevention, Harvard Pilgrim Health Care Institute, HCA Healthcare and UCI Health Identifies Best Strategy to Prevent Life-Threatening Health Care-Associated ICU Infections

October 10, 2023 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Large Clinical Trial by the Centers for Disease Control and Prevention, Harvard Pilgrim Health Care Institute, HCA Healthcare and UCI Health Identifies Best Strategy to Prevent Life-Threatening Health Care-Associated ICU Infections

NASHVILLE, Tenn. & ORANGE, Calif. & ATLANTA & BOSTON–(BUSINESS WIRE)–A large multi-state study by the Centers for Disease Control and Prevention, Harvard Pilgrim Health Care Institute, HCA Healthcare and the University of California, Irvine has found that a nasal antibiotic ointment, mupirocin, which is currently used daily for intensive care…
Click here to view original post